U.S. Markets open in 7 hrs 13 mins

Allergan plc (AGN)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
222.27-1.48 (-0.66%)
At close: 4:02PM EDT
People also watch
BIIBCELGVRXGILDREGN
  • M
    Mehran
    Mehran
    OMG, what is happening Thurston? What is going on? We r going higher instead of lower; how could this be?
  • G
    GeraldF
    GeraldF
    What is NOT to like with this stock: Incredible pipeline, huge cash flow, much of its revenue is paid out of pocket, by rich folks, who simply want to modify their face butt, and boobs ! This group of happy customers, for Botox, will continue to grow, at an ACCELERATED pace ! Allergan is NOT dependent upon insurance companies to reimburse them for one of their MOST PROFITABLE products ! Let's add to that: A good possibility for tax-favorable improvements to their bottom line. Let's add to that: A simply great company, with many good molecules that people not only need, but are willing to pay for. Cheers to all ! -Frieberg, long AGN, GILD, and will soon be buying into some BMRN and ABBV.
  • J
    Joe
    Joe
    It's obvious now who Thurston is! He's paid/works for Seven Corners Capital management to bad mouth AGN and try to drive the price down to their suggested price target of $117! What a joke!
  • B
    B Yan
    B Yan
    Great change to buy AGN. It is just too cheap as Jim Cramer said.
  • u
    unimpressedinweston
    unimpressedinweston
    Does anyone find this comment remarkably familiar?

    "$AGN ...lmao...I told you sheep 2 months ago this was going to $180...it was $260 then...$224 now....and dropping every day!! saunders..lol"

    This is from CNN with the name Sonofsam Aug. 17 at 1:42 PM. Tuna, Thurston, Sonofsam are all irritants. Glad my mute works. John is next.
  • T
    Thurston
    Thurston
    I bet they can make more revenue by selling the hilarious interviews given by the colonel . People would pay for the comedy. Colonel Saunders needs to be in the media even faster so the bankruotcy will be wuick
  • T
    Thurston
    Thurston
    Although “Performance Net Income Per Share” increased by 20% for the three months ended June 30, 2017 (from $3.35 to $4.02), this was almost entirely due to share repurchases rather than underlying operational performance. Aggregate non-GAAP Performance Net Income increased just $37 million year-over-year in the second quarter, or 2.65%, and actually decreased by $17 million year-over-year in the first half of 2017, down 6/10th of one percent.
  • F
    Finkelstein
    Finkelstein

    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M / 17 FDA approved products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..GLTA

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.1 Million
    Cash: $12.6 Million
    Price: $5.15

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • T
    Thurston
    Thurston
    Odds are high we take out new lows before thanksgiving maybe earlier. That I have a high degree of confidence in. Contact me any time thurston . We can go fir drinks.
  • G
    GeraldF
    GeraldF
    oversold territory. buy.
  • T
    Thurston
    Thurston
    They geese get your takes out ... matter of fact I should get my take out to wreck you grad and TGE. Earxz cgrrsrsburger
  • T
    Thurston
    Thurston
    AGN has cratered but that's not the bigtin
  • T
    Thurston
    Thurston
    Tomorrow is a massacre good luck riding the hog luwer
  • T
    Thurston
    Thurston
    AGN worth no more than 217
  • T
    Thurston
    Thurston
    Look for 310 to break thus week AGN a total manipulated financial entiry
  • T
    Thurston
    Thurston
    AGN management is at a loss they have floundered every step of the way niwctgey are at a liss
  • T
    Thurston
    Thurston
    The market more and mire is saying AGN is nothing but s fraud
  • T
    Thurston
    Thurston
    Hey geese I can guarantee another diwn day and quite possibly a big one!!
  • T
    Thurston
    Thurston
    Well the steak ended but not in a way that shows any promise for the company. Hey geese if you consider this an up day than you are going to be sorely disappointed. This is about as bad as it gets when a sector and broad market soars and garbage like AGN is basically flat. I reiterate it will fall to 210 this week on any small weakness in market
  • T
    Thurston
    Thurston
    Good god geese what is your stop on this terrible investment